Eighty seven patients with chronic heart failure ( > or = 60 years old ) were randomly divided into 2 groups : the CHF control group ( n = 46 ) who received regular therapy and the CHF experimental group ( n = 41 ) who received regular therapy and recombinant human growth hormone .